Elevai Labs, Inc., a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc. and changed its name to Elevai Labs, Inc. in December 2021. Elevai Labs, Inc. was incorporated in 2020 and is based in Newport Beach, California.
Employees - 2,
CEO - Mr. Graydon Bensler C.F.A.,
Sector - Healthcare,
Country - US,
Market Cap - 1.63M
Altman ZScore(max is 10): -2.3, Piotroski Score(max is 10): 2, Working Capital: $4251867, Total Assets: $8993165, Retained Earnings: $-13269627, EBIT: -3281517, Total Liabilities: $2333601, Revenue: $0
AryaFin Target Price - $0.5 - Current Price $2.30 - Analyst Target Price $-
| Ticker | ELAB |
| Index | - |
| Curent Price | 2.30 |
| Change | 3.61% |
| Market Cap | 1.63M |
| Average Volume | 511.83K |
| Income | -5.47M |
| Sales | 2.45M |
| Book Value/Share | 242.57 |
| Cash/Share | 9.09 |
| Dividend Est | - |
| Dividend TTM | - |
| Dividend Ex-Date | - |
| Employees | 3 |
| Moving Avg 20days | -33.51% |
| Moving Avg 50days | -60.08% |
| Moving Avg 200days | -98.56% |
| Shares Outstanding | 0.71M |
| Earnings Date | - |
| Inst. Ownership | 0.87% |
| Price/Earnings | - |
| Forwad P/E | - |
| PE Growth | - |
| Price/Sales | 0.66 |
| Price/Book | 0.01 |
| Price/Cash | 0.25 |
| Price/FCF | - |
| Quick Ratio | 3.40 |
| Current Ratio | 3.86 |
| Debt/Equity | 0.01 |
| Return on Assets | -85.53% |
| Return on Equity | -130.35% |
| Return on Investment | -63.92% |
| Gross Margin | 70.00% |
| Ops Margin | -207.86% |
| Profit Margin | -223.57% |
| RSI | 29.10 |
| BETA(β) | -0.72 |
| From 52week Low | 6.98% |
| From 52week High | -99.78% |
| EPS | -409.35 |
| EPS next Year | - |
| EPS next Qtr | - |
| EPS this Year | - |
| EPS next 5 Year | - |
| EPS past 5 Year | - |
| Sales past 5 Year | 30819.15% |
| EPS Y/Y | - |
| Sales Y/Y | - |
| EPS Q/Q | 13.27% |
| Sales Q/Q | -4.90% |
| Sales Surprise | - |
| EPS Surprise | - |
| ATR(14) | 0.64 |
| Perf Week | -11.53% |
| Perf Month | -54.90% |
| Perf Quarter | -89.40% |
| Perf Year | -99.73% |
| Perf YTD | -85.65% |
| Target Price | - |
AryaFin Engine© - An AI FinTech Venture - 2024-25 Disclaimer